A Novel Tool for the Risk Assessment and Personalized Chemo-/Immunotherapy Response Prediction of Adenocarcinoma and Squamous Cell Carcinoma Lung Cancer-Reference-Cited by-同舟云学术

A Novel Tool for the Risk Assessment and Personalized Chemo-/Immunotherapy Response Prediction of Adenocarcinoma and Squamous Cell Carcinoma Lung Cancer

Published:2021-09 Issue: Volume:Volume 14 Page:5771-5785
ISSN:1178-7074
Container-title:International Journal of General Medicine
language:en
Short-container-title:IJGM

Author:

Chen Hai^ORCID,Xu Xianquan^ORCID,Ge Tengfei,Hua Congshu,Zhu Xiaodong,Wang Qikui,Yu Zaicheng,Zhang Renquan

Publisher

Informa UK Limited

Subject

General Medicine

Reference43 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Lung Cancer Statistics

3. Cancer treatment and survivorship statistics, 2019

4. Cancer Genome Atlas Research N. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014;511(7511):543–550. doi: 10.1038/nature13385.

5. Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Subclassification of lung adenocarcinoma through comprehensive multi-omics data to benefit survival outcomes;Computational Biology and Chemistry;2024-10

2. Optimizing Image Quality: Exploring Preprocessing Filtering Methods for Medical Lung CT-Scan Analysis;SSRN Electronic Journal;2024

3. Lung and colon cancer detection from CT images using Deep Learning;Machine Graphics and Vision;2023-08-10

4. Costimulatory molecule‐ related lncRNA model as a potential prognostic biomarker in non‐small cell lung cancer;Cancer Medicine;2022-10-28